Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease (2024)
- Authors:
- USP affiliated authors: SORIANO, FRANCISCO GARCIA - FM ; RONSEIN, GRAZIELLA ELIZA - IQ ; PASSARELLI, MARISA - FM ; SANTANA, MONIQUE DE FATIMA MELLO - FM ; SOUZA JUNIOR, DOUGLAS RICARDO DE - IQ
- Unidades: FM; IQ
- DOI: 10.3390/cells13161327
- Subjects: NEOPLASIAS MAMÁRIAS; PROTEÔMICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SANTANA, Monique de Fátima Mello et al. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease. Cells, v. 13, p. 1-19 art. 1327, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cells13161327. Acesso em: 02 jan. 2026. -
APA
Santana, M. de F. M., Sawada, M. I. B. A. C., Souza Junior, D. R. de, Giacaglia, M. B., Reis, M., Xavier, J., et al. (2024). Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease. Cells, 13, 1-19 art. 1327. doi:10.3390/cells13161327 -
NLM
Santana M de FM, Sawada MIBAC, Souza Junior DR de, Giacaglia MB, Reis M, Xavier J, Giannella MLCC, Soriano FG, Gebrim LH, Ronsein GE, Passarelli M. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease [Internet]. Cells. 2024 ; 13 1-19 art. 1327.[citado 2026 jan. 02 ] Available from: https://dx.doi.org/10.3390/cells13161327 -
Vancouver
Santana M de FM, Sawada MIBAC, Souza Junior DR de, Giacaglia MB, Reis M, Xavier J, Giannella MLCC, Soriano FG, Gebrim LH, Ronsein GE, Passarelli M. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease [Internet]. Cells. 2024 ; 13 1-19 art. 1327.[citado 2026 jan. 02 ] Available from: https://dx.doi.org/10.3390/cells13161327 - Increased Expression of miR-223-3p and miR-375-3p and Anti-Inflammatory Activity in HDL of Newly Diagnosed Women in Advanced Stages of Breast Cancer
- HDL isolated by immunoaffinity, ultracentrifugation, or precipitation is compositionally and functionally distinct
- Strategies for consistent and automated quantification of HDL proteome using data-independent acquisition
- Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study
- Data-Iindependent Acquisition (DIA): an Approach to Quantify HDL Proteome with Precision
- Robust quantification of HDL proteome for mechanistic and clinical studies
- Perfil de microRNAs, proteoma e funcionalidade da HDL são distintos em mulheres com câncer de mama em comparação a controles: associação com a classificação molecular e estágio tumoral
- Enriquecimento da HDL em apolipoproteína A-IV favorece sua funcionalidade na doença renal diabética
- Comparing data-Independent acquisition and parallel reaction monitoring in their abilities to differentiate high-density lipoprotein subclasses
- High-density lipoprotein remodeling associates with COVID-19 severity: a quantitative proteomic study
Informações sobre o DOI: 10.3390/cells13161327 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3213195.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
